J&J, Merck, Endo Probed Over Pharmacy Benefit Managers

Federal prosecutors in Manhattan have asked drugmakers including Johnson & Johnson, Merck and Endo for information regarding contracts with pharmacy benefit managers in connection with a False Claims Act investigation, according...

Already a subscriber? Click here to view full article